SEC Form 4 · accession 0001104659-15-020456
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey S. Hatfield
Officer — Chief Executive Officer · Director
Period of report
Mar 13, 2015
Accepted (ET)
Mar 17, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 13, 2015 | F | 171,156 | $11.16 | D | 267,360 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Issuer withheld these shares to satisfy the Reporting Person's tax liability resulting from the settlement of certain restricted stock units.